Roy Turner is an experienced professional in the pharmaceutical industry, currently serving as the Preclinical CMC People & Strategy Area Lead at Roche since March 2024. Prior to this role, Roy held various leadership positions at Idorsia Pharmaceuticals Ltd, including Director of Team Lead for Parenteral Dosage Forms and Combinations Products, and has been responsible for the technical development and execution of multiple projects. With earlier experience at Actelion and Novartis in CMC leadership roles, Roy has a strong background in paediatric drug development, formulation development, and analytical methods. Educational qualifications include a PhD in Pharmaceutics from The School of Pharmacy, University of London, and advanced degrees in Pharmaceutical Analysis and Quality Control, as well as Pharmacology from King's College London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices